EA

Eagle Veterinary Technology Co.,Ltd

Manufactures vet pharma for livestock/aquaculture & distributes premium pet food.

044960 | KO

Overview

Corporate Details

ISIN(s):
KR7044960003
LEI:
Country:
South Korea
Address:
충청남도 예산군 신암면 추사로 235-34, 예산군
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1970, Eagle Veterinary Technology Co., Ltd. is a specialized company in animal health, manufacturing and distributing veterinary pharmaceuticals and premium pet food. Its pharmaceutical division serves the livestock (cattle, swine, poultry) and aquaculture industries, offering a range of products including antibiotics, anthelmintics, and innovative bio-feeds developed through partnerships with global firms. The companion animal division, Haruwell, focuses on the premium market by distributing international brands like Now Fresh, Go! Solutions, and CARU, while also developing its own functional product lines such as the 'Probiomil' probiotic feed and 'SUMMIT' tailored nutrition diets. The company is committed to research and development to improve animal well-being and actively engages with its markets through industry seminars, consumer expos, and corporate social responsibility initiatives.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.0 MB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.0 MB
2025-03-19 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 20.9 KB
2025-03-11 00:00
Audit Report / Information
감사보고서제출
Korean 17.7 KB
2025-03-11 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 652.9 KB
2025-02-21 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 178.9 KB
2025-02-11 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 9.0 KB
2025-02-04 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 8.7 KB
2024-11-14 00:00
Quarterly Report
분기보고서 (2024.09)
Korean 870.7 KB
2024-08-14 00:00
Interim Report
반기보고서 (2024.06)
Korean 864.9 KB
2024-05-16 00:00
Quarterly Report
분기보고서 (2024.03)
Korean 873.5 KB
2024-03-29 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 23.0 KB
2024-03-21 00:00
Audit Report / Information
사업보고서 (2023.12)
Korean 548.1 KB
2024-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 17.7 KB
2024-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 166.2 KB

Automate Your Workflow. Get a real-time feed of all Eagle Veterinary Technology Co.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Eagle Veterinary Technology Co.,Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Eagle Veterinary Technology Co.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

SOLIGENIX, INC. Logo
Late-stage biopharma developing treatments for rare diseases and public health threats.
United States of America
SNGX
Sonnet BioTherapeutics Holdings, Inc. Logo
Develops targeted cytokine therapies for cancer using a proprietary albumin-binding platform.
United States of America
SONN
Sonoma Pharmaceuticals, Inc. Logo
Develops and sells stabilized HOCl products for wound, skin, eye, nasal, and animal healthcare.
United States of America
SNOA
Sopharma AD Logo
Develops, manufactures, and distributes pharmaceuticals and generics in Bulgaria and regional markets.
Bulgaria
SFA
Spago Nanomedical AB Logo
Developing nanomedicines for precise cancer diagnosis and targeted radionuclide therapy.
Sweden
SPAGO
Spero Therapeutics, Inc. Logo
Develops novel treatments for multi-drug resistant bacterial infections and rare diseases.
United States of America
SPRO
Spexis AG Logo
Clinical-stage biopharma developing macrocyclic therapeutics for rare diseases and oncology.
Switzerland
SPEX
Sprint Bioscience Logo
Develops & out-licenses preclinical oncology drugs for difficult-to-treat cancers.
Sweden
SPRINT
SPRUCE BIOSCIENCES, INC. Logo
Developing first-in-class therapies for serious, underserved neurological conditions like MPS IIIB.
United States of America
SPRB
Spyre Therapeutics, Inc. Logo
Engineering advanced antibody therapies for IBD and other immune diseases.
United States of America
SYRE

Talk to a Data Expert

Have a question? We'll get back to you promptly.